Journal
CLINICAL NUCLEAR MEDICINE
Volume 40, Issue 4, Pages 309-313Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RLU.0000000000000670
Keywords
oncocytoma; renal cell carcinoma; Tc-99m-MIBI; SPECT/CT
Funding
- Buerger Family Scholar Fund
- National Kidney Foundation of Maryland
Ask authors/readers for more resources
Purpose: The differentiation of oncocytoma from renal cell carcinoma (RCC) remains a challenge with currently available cross-sectional imaging techniques. As a result, a large number of patients harboring a benign oncocytoma undergo unnecessary surgical resection. In this study, we explored the utility of Tc-99m-MIBI SPECT/CT for the differentiation of these tumors based on the hypothesis that the large number of mitochondria in oncocytomas would lead to increased Tc-99m-MIBI uptake. Patients and Methods: In total, 6 patients (3 with oncocytoma and 3 with RCC) were imaged with Tc-99m-MIBI SPECT/CT. Relative quantification was performed by measuring tumor-to-normal renal parenchyma background ratios. Results: All 3 oncocytomas demonstrated radiotracer uptake near or above the normal renal parenchymal uptake (range of uptake ratios, 0.85-1.78). In contrast, the 3 RCCs were profoundly photopenic relative to renal background (range of uptake ratios, 0.21-0.31). Conclusions: Tc-99m-MIBI SPECT/CTappears to be of value in scintigraphically distinguishing benign renal oncocytoma from RCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available